1. Platinum compounds in cancer therapy;Kelland;Curr. Opin. Oncol., Endocrine, Metabolic Invest. Drugs,1999
2. In vitro circumvention of cisplatin-resistance by the novel sterically hindered platinum complex AMD473;Holford;Br. J. Cancer,1998
3. Mechanisms of drug resistance to the platinum complex ZD0473 in ovarian cancer cell lines;Holford;Eur. J. Cancer,2000
4. Cis-amminedichloro(2-methylpyridine) platinum(II) (AMD473), a novel sterically hindered platinum complex;Raynaud;Clin. Cancer Res.,1997
5. Trigo JM, Beale P, Judson IR, et al. Phase I and pharmacokinetic study of cis-amminedichloro (2-methylpyridine) platinum (II) (ZD0473), a novel sterically-hindered platinum complex, in patients with advanced solid malignancies. Proceedings of ASCO 1999, 18 (abstr) Ab48.